1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Neurorehabilitation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Neurorehabilitation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Neurorehabilitation Devices Market Regional Analysis
6.2 South & Central America Neurorehabilitation Devices Market Revenue 2021-2031 (US$ Million)
6.3 South & Central America Neurorehabilitation Devices Market Forecast Analysis
7. South & Central America Neurorehabilitation Devices Market Analysis – by Product Type
7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. South & Central America Neurorehabilitation Devices Market Analysis – by Application
8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson\'s Disease
- 8.4.1 Overview
- 8.4.2 Parkinson\'s Disease: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. South & Central America Neurorehabilitation Devices Market Analysis – by End User
9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: South & Central America Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. South & Central America Neurorehabilitation Devices Market – South & Central America Analysis
10.1 Overview
10.2 South & Central America
- 10.2.1 South & Central America Neurorehabilitation Devices Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 10.2.1.1 South & Central America Neurorehabilitation Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South & Central America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Brazil: South & Central America Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 Brazil: South & Central America Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.1.3 Brazil: South & Central America Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.2 Argentina:
South & Central America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Argentina: South & Central America Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Argentina: South & Central America Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.2.3 Argentina: South & Central America Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.3 Rest of South & Central America:
South & Central America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Rest of South & Central America: South & Central America Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 Rest of South & Central America: South & Central America Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.3.3 Rest of South & Central America: South & Central America Neurorehabilitation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BIONIK
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BioXtreme Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Blackrock Microsystems Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ekso Bionics Holdings Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 EMOTIV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hocoma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medtronic Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Renishaw Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Tyromotion GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations